Treatment

The Largest Phase 3 Trial on Psilocybin for Depression Has Kicked Off

The Largest Phase 3 Trial on Psilocybin for Depression Has Kicked Off

,
The largest Phase 3 clinical trial investigating the efficacy and tolerability of psilocybin for treatment-resistant depression (TRD) has finally begun.
psilocybin for depression

Single Dose of Psilocybin Yields Long-Term Depression Remission in Over 50% of Cancer Patients

,
A single 25mg dose of psilocybin paired with psychological support has resulted in 57% of patients.
MEAI: The Non-Hallucinogenic Psychedelic with an 'Enough Switch' for Addictions

MEAI: The Non-Hallucinogenic Psychedelic with an ‘Enough Switch' for Addictions

,
MEAI seems to function like an “enough switch” in the brain, stopping all further desire for alcohol or cocaine and preventing overuse.
A "Trip-Less" Alternative? Non-Hallucinogenic LSD Analog Shows Promise for Treating Mood Disorders

A “Trip-Less” Alternative? Non-Hallucinogenic LSD Analog Shows Promise for Treating Mood Disorders

,
A non-hallucinogenic LSD analogue may be able to treat mood disorders and chronic stress without the hallucinations.
Oregon psilocybin therapy costs

Oregon's First Licensed Psilocybin Center Charges $2800 for One Session: Are the Costs Justifiable?

,
Taking an objective look at Oregon's first licensed psilocybin center costs. Is $2800 - $3500 for one session justifiable?
The Biggest Psychedelic News Stories on the Week - May 5

The Biggest Psychedelic News Stories of the Week – May 5

,
The psychedelic news scene continues to be constantly evolving, with new developments emerging from various states across the country.
psychedelic clinical trials

Want to Try Psychedelics in a Clinical Setting? 116 Trials Now Recruiting Volunteers (UPDATED)

,
Here's how to become a research subject for psilocybin, LSD, MDMA, ibogaine, DMT and 5-MeO-DMT studies.
Experts Propose Solutions for Regulatory Challenges in the Psychedelic Field

Experts Propose Solutions for Regulatory Challenges in the Psychedelic Field

,
New paper published in Science proposes expert solutions for regulatory challenges in the psychedelic field.
The Biggest Psychedelic News Stories of This Week - April 28

The Biggest Psychedelic News Stories of This Week – April 28

,
Some of the biggest psychedelic news this week include the Colorado Senate passing a bill to regulate psychedelics.

© 2022 Psychedelic Spotlight. | Owned and operated by PSYC Media Corporation, Inc. a US publicly traded company (OTCPink: PSYC) | All Rights Reserved.